Les cancers à petites cellules : que faire en cas de rechute ?

Small cell lung cancer accounts for about 13% of all lung cancers. While its sensitivity to first-line chemotherapy is high, it is characterized by a particularly high relapse rate. The objective of this paper is to review the therapeutic options available today for patients with relapsed small cell lung cancer and to highlight the most promising experimental treatments.